Pharmacy Scope of Services
Administration of Cancer Chemotherapy
Administration of Hazardous Drugs
Administration of Medications with Dose and Frequency Ranges, Multiple Analgesic Orders
Adult Extravasation Management (Vesicants)
Adverse Drug Event Reporting
Automated Medication Dispensing Cabinet (Omnicell) Procedure
Barcoded Medication Administration
Birth Place Hypertension Policy
CIWA (Clinical Institute Withdrawal Assessment) Protocol
Clostridium Difficile Policy
Compounded Sterile Preparations Standard Operating Policy
Concentrated Electrolytes
Drug Diversion Policy
DKA or HHS Policy
Drug Samples Policy
ED Procedural Sedation
ED To-Go Medications Policy
Formulary Addition Request Form
Formulary: Non-Formulary Drugs
High Alert Medication Policy
HIV Postexposure Prophylaxis
HIV PEP Kit Procedure
Home Medications
ICU Drip Chart
Inspections: Medication Areas (Floor Stock)
Investigational Drugs Policy
IV to PO Conversion Policy
Labeling and Dispensing Policy
Look-Alike / Sound-Alike Drugs
Medication Administration Standards
Medication Administration through Enteral Feeding Tubes
Medication Ordering and Processing Policy
Medication Reconciliation
Medications Sent Home With Patients
Nasal MRSA PCR Protocol
Non-Formulary Request Form
Patient Controlled Analgesia
Pediatric and Adolescent Patients Intravenous Therapy
Peripheral IV Therapy Policy
Pre-Operative Medications
Rabies Exposure Policy
Renal Dosing Program
Restricted Antibiotics List
Restricted ICS Medications
Safe Ordering Practices for Chemotherapy Agents
Self-Administration of Medications
Stop Order Policy For Acute Care Patients
Stop Order Policy For Hospital-Based Skilled Nursing Facility Patients
Titrated Medications
TPN Policy
Transdermal Analgesia for Pediatric Patients
Unacceptable Abbreviations List
Adult Pharmacokinetic Dosing Protocol
AMI with Stent 30 Day Supply of Plavix Workflow
Reversal of Oral Angicoagulants
Anticoagulant Monitoring Guidelines
Anticoagulant Transitions
Beta-Lactam Antibiotic Use in Patients With Reported Allergic Reactions to Beta-Lactam Agents
Controlled Substances
Herbal Supplement Products Policy
Nutritional Products
Retention Enemas: Kayexalate Enema, Milk and Molasses Enema
Treatment of Significant Hyponatremia with Hypertonic Saline
Influenza-Pneumococcal Vaccination Protocol
Respiratory Medications Policy
Long-acting Beta Agonist/Short-acting Beta Agonist Inhalation Medication Policy
Medications Requiring Cardiac and/or Special Monitoring
Corticosteroid Taperpack Policy
Alteplase Infusion for Acute Ischemic Stroke, Myocardial Infarction and Pulmonary Embolus
buprenorphine/methadone Policy
clozapine (Clozaril) Policy
enoxaparin (Lovenox) Policy
fentanyl intra-nasal ED Use For Pediatric Patients Policy
fondaparinux (Arixtra) Monitoring Protocol
Heparin Prophylaxis Monitoring Program
IV Heparin Administration (Anti-Xa based)
IV Immune Globulin Policy
IV Lidocaine in the ED for Acute Pain
Humulin U-500 Insulin Policy
Insulin Pump Policy
Insulin Pump Entry Instructions
Lidocaine Use with IV insertion
Management of Bleeding Events with dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis)
meropenem (Merrem) Policy
metFORMIN in Patients Receiving Iodinated IV Contrast
methadone/buprenorphine Policy
midazolam (Versed)
midazolam intra-nasal ED Use For Pediatric Patients Policy
mitoMYcin Intravesicular
NOWS Morphine Treatment Protocol
IV phenytoin (Dilantin) Policy
piperacillin-tazobactam (Zosyn) Extended Dosing Interval Policy
Potassium Chloride IV Policies
promethazine (Phenergan) IV Policy
tirofiban (Aggrastat) Policy
Vitamin K Route Substitution For Reversal of Warfarin (Coumadin)
Vitamin K guidelines
Add Formweb to your mobile device
